Skip to content
10-Q

Quarterly Report

AngioDynamics, Inc. ANGO

0001275187-26-000003

← back to feed
Filed
Jan 6, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Jan 2, 2026 41.22M sh
Shares Diluted Q2 2026 · Nov 30, 2025 41.54M sh
Shares Diluted Q2 2026 · Nov 30, 2025 41.4M sh
Shares Diluted Q2 2026 · Nov 30, 2024 40.92M sh
Shares Diluted Q2 2026 · Nov 30, 2024 40.79M sh
Stock Repurchased Q2 2026 · Nov 30, 2025 $0
Stock Repurchased Q2 2026 · Nov 30, 2024 $1.67M
Capex Q2 2026 · Nov 30, 2025 $1.15M
Capex Q2 2026 · Nov 30, 2024 $1.89M
Operating Cash Flow Q2 2026 · Nov 30, 2025 −$11.25M
Operating Cash Flow Q2 2026 · Nov 30, 2024 −$15.78M
Cash And Equivalents Q2 2026 · Nov 30, 2025 $41.64M
Cash And Equivalents Q2 2026 · May 31, 2025 $55.89M
Stockholders Equity Q2 2026 · Nov 30, 2025 $176.33M
Stockholders Equity Q2 2026 · Aug 31, 2025 $178.86M
Stockholders Equity Q2 2026 · May 31, 2025 $182.97M
Stockholders Equity Q2 2026 · Nov 30, 2024 $186.77M
Stockholders Equity Q2 2026 · Aug 31, 2024 $196.58M
Stockholders Equity Q2 2026 · May 31, 2024 $205.59M
Current Liabilities Q2 2026 · Nov 30, 2025 $71.96M
Current Liabilities Q2 2026 · May 31, 2025 $76.2M
Total Liabilities Q2 2026 · Nov 30, 2025 $93.35M
Total Liabilities Q2 2026 · May 31, 2025 $97.17M
Current Assets Q2 2026 · Nov 30, 2025 $161.35M
Current Assets Q2 2026 · May 31, 2025 $168.32M
Total Assets Q2 2026 · Nov 30, 2025 $269.68M
Total Assets Q2 2026 · May 31, 2025 $280.14M
Eps Diluted Q2 2026 · Nov 30, 2025 −$0.15
Eps Diluted Q2 2026 · Nov 30, 2025 −$0.42
Eps Diluted Q2 2026 · Nov 30, 2024 −$0.26
Eps Diluted Q2 2026 · Nov 30, 2024 −$0.58
Eps Basic Q2 2026 · Nov 30, 2025 −$0.15
Eps Basic Q2 2026 · Nov 30, 2025 −$0.42
Eps Basic Q2 2026 · Nov 30, 2024 −$0.26
Eps Basic Q2 2026 · Nov 30, 2024 −$0.58
Sga Expense Q2 2026 · Nov 30, 2025 $10.15M
Sga Expense Q2 2026 · Nov 30, 2025 $22.71M
Sga Expense Q2 2026 · Nov 30, 2024 $10.39M
Sga Expense Q2 2026 · Nov 30, 2024 $21.37M
Rd Expense Q2 2026 · Nov 30, 2025 $7.77M
Rd Expense Q2 2026 · Nov 30, 2025 $14.19M
Rd Expense Q2 2026 · Nov 30, 2024 $6.43M
Rd Expense Q2 2026 · Nov 30, 2024 $12.72M
Net Income Q2 2026 · Nov 30, 2025 −$6.35M
Net Income Q2 2026 · Nov 30, 2025 −$17.25M
Net Income Q2 2026 · Aug 31, 2025 −$10.9M
Net Income Q2 2026 · Nov 30, 2024 −$10.74M
Net Income Q2 2026 · Nov 30, 2024 −$23.54M
Net Income Q2 2026 · Aug 31, 2024 −$12.8M
Operating Income Q2 2026 · Nov 30, 2025 −$6.13M
Operating Income Q2 2026 · Nov 30, 2025 −$16.78M
Operating Income Q2 2026 · Nov 30, 2024 −$11.09M
Operating Income Q2 2026 · Nov 30, 2024 −$24.19M
Gross Profit Q2 2026 · Nov 30, 2025 $44.78M
Gross Profit Q2 2026 · Nov 30, 2025 $86.64M
Gross Profit Q2 2026 · Nov 30, 2024 $39.91M
Gross Profit Q2 2026 · Nov 30, 2024 $76.63M
Cost Of Revenue Q2 2026 · Nov 30, 2025 $34.65M
Cost Of Revenue Q2 2026 · Nov 30, 2025 $68.5M
Cost Of Revenue Q2 2026 · Nov 30, 2024 $32.94M
Cost Of Revenue Q2 2026 · Nov 30, 2024 $63.71M
Revenue Q2 2026 · Nov 30, 2025 $79.43M
Revenue Q2 2026 · Nov 30, 2025 $155.14M
Revenue Q2 2026 · Nov 30, 2024 $72.85M
Revenue Q2 2026 · Nov 30, 2024 $140.34M